Stockholm Stock Exchange | Large Cap
Vitrolife
+58.99%
Latest
+60.07%
3 months
DNB CarnegieCarnegieSEBSEB EquitiesHandelsbankenDNBHandelsbanken Capital MarketsDNB Markets

Price Targets For Vitrolife

AnalystPrice TargetDateUpside
DNB Carnegie245 SEKJun 11
+58.99%
Carnegie265 SEKMar 20
SEB230 SEKMar 19
SEB Equities275 SEKOct -24
Handelsbanken250 SEKJul -24
DNB250 SEKJul -24
Handelsbanken Capital Markets220 SEKJan -24
DNB Markets220 SEKJan -24

About The Company

Vitrolife is a Swedish medtech company which sells products for IVF treatment.
Wikipedia